AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slid 1.55% to $157.17 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.28% to 3,969.61 and the Dow Jones Industrial Average rising 0.80% to 33,973.01. This was the stock's third consecutive day of losses. AbbVie Inc. closed $18.74 short of its 52-week high ($175.91), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.16% to $174.88 and Pfizer Inc. (PFE) fell 0.36% to $47.45. Trading volume (7.5 M) eclipsed its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 11, 2023.
(END) Dow Jones Newswires
January 11, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.